Taiwan Firm AHEAD Medicine Disrupting Cell Analysis With AI to Help Accelerate Disease Diagnostics and Cell Therapy Worldwide
July 29 2022
AHEAD Medicine, a UC Berkeley SkyDeck-backed company has launched a new AI-enabled cell immuno-profiling analysis […]